Grant opportunity
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
National Institutes of Health has posted Alzheimer's Drug-Development Program (U01 Clinical Trial Optional), a health and biomedical sciences funding opportunity listed on Grants.gov under opportunity number RFA-AG-28-009. The call is relevant to Private institutions of higher education; Special district governments; Native American tribal governments (Federally recognized); City or township governments; Public and State controlled institutions of higher education; Independent school districts; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); For profit organizations other than small businesses; State governments; Public housing authorities/Indian housing authorities; County governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education and should be reviewed on the official listing for final eligibility, forms, attachments and submission timing.
- Funder
- National Institutes of Health
- Forecasted close date / see official listing
- Forecasted close date / see official listing
- Award
- See official Grants.gov listing
- Applicant
- Private institutions of higher education; Special district governments; Native American tribal governments (Federally recognized); City or township governments; Public and State controlled institutions of higher education; Independent school districts; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); For profit organizations other than small businesses; State governments; Public housing authorities/Indian housing authorities; County governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Discipline
- Health and Biomedical Sciences
- Region
- United States
- Posted
- Aug 13, 2026
Call summary
Overview
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) is an official Grants.gov opportunity from National Institutes of Health. It appears under opportunity number RFA-AG-28-009 and is listed for applicants working in health and biomedical sciences.
Who can apply
Private institutions of higher education; Special district governments; Native American tribal governments (Federally recognized); City or township governments; Public and State controlled institutions of higher education; Independent school districts; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); For profit organizations other than small businesses; State governments; Public housing authorities/Indian housing authorities; County governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education. Applicants should confirm all additional eligibility limits, cost-sharing rules, institutional requirements and application package instructions on the official Grants.gov page.
What it supports
- Opportunity number: RFA-AG-28-009
- Funding category: Health
- Funding instrument: Cooperative Agreement
Funding and duration
See official Grants.gov listing
Forecasted close date / see official listing
Forecasted close date / see official listing
How to apply
Open the official Grants.gov listing, review the full notice of funding opportunity and application package, then submit through the Grants.gov route specified by the agency.
Call details
Source-based overview
National Institutes of Health has posted Alzheimer's Drug-Development Program (U01 Clinical Trial Optional), a health and biomedical sciences funding opportunity listed on Grants.gov under opportunity number RFA-AG-28-009. The call is relevant to Private institutions of higher education; Special district governments; Native American tribal governments (Federally recognized); City or township governments; Public and State controlled institutions of higher education; Independent school districts; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); For profit organizations other than small businesses; State governments; Public housing authorities/Indian housing authorities; County governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education and should be reviewed on the official listing for final eligibility, forms, attachments and submission timing.
Eligibility
Private institutions of higher education; Special district governments; Native American tribal governments (Federally recognized); City or township governments; Public and State controlled institutions of higher education; Independent school districts; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); For profit organizations other than small businesses; State governments; Public housing authorities/Indian housing authorities; County governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education. Applicants should confirm all additional eligibility limits, cost-sharing rules, institutional requirements and application package instructions on the official Grants.gov page.
Funding and benefits
See official Grants.gov listing
Themes and supported activities
Opportunity number: RFA-AG-28-009
Funding category: Health
Funding instrument: Cooperative Agreement
Deadline and timeline
Forecasted close date / see official listing: Forecasted close date / see official listing.
Applicants should confirm the exact deadline time, time zone, required documents, portal steps and any institutional approvals on the official call page before submitting.
How to apply
Open the official Grants.gov listing, review the full notice of funding opportunity and application package, then submit through the Grants.gov route specified by the agency.
Before applying, check eligibility rules, budgets, attachments, page limits, partner requirements, cost-share conditions and whether the opportunity uses an expression of interest, full proposal, registration or nomination stage.